Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research
The Mount Sinai Health System will work with Columbia Care LLC, a provider of medical marijuana, on research projects that evaluate the potential of related, experimental treatments. The collaboration moves into the next phase with the recent decision by the New York State Department of Health to award Columbia Care one of five state licenses to produce and dispense medical marijuana.
Mount Sinai and Columbia Care are already cooperating on analyses of the company’s patient registry data, with the goal to generate evidence about whether or not medical marijuana can help cancer patients regain lost weight or reduce nerve pain in HIV patients. The company has the largest national medical marijuana patient registry, with data derived from more than 100,000 patient interactions in 20 disease categories.
Mount Sinai and other state institutions are working work with Columbia Care to establish the New York State Medical Marijuana Research Network (MMRN). Mount Sinai will serve as the MMRN data and clinical coordination center, and will also advise Columbia Care on how to secure planned dispensaries and comply with regulations.
“We look forward to conducting rigorous scientific studies that answer the question of whether or not marijuana has value in the treatment of diseases where patients need more options,” said David L. Reich, MD, President and Chief Operating Officer, The Mount Sinai Hospital. “Should preliminary data from registry research support this and regulations allow, we may collaborate on future clinical trials that confirm the efficacy of related treatments.”
“Mount Sinai is committed to innovation in medicine, and we believe that well conducted, condition-specific studies on treatment with cannabis will answer important questions,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs for the Mount Sinai Health System. “Progress has been slowed by a paucity of rigorous studies, and our plan is to address that.”
With its New York license in place, Columbia Care is now licensed to operate research-focused, medical marijuana programs in five states and in Washington, D.C. "Columbia Care was founded to improve and rehabilitate lives and communities," said Columbia Care CEO Nicholas Vita. "Our activities are limited to marijuana for medical use and we emphasize health and healing through proven science. We are proud to partner with one of the most prestigious research and medical institutions globally in Mount Sinai.”
About Columbia Care
Columbia Care is one of the nation's largest providers of medical marijuana. Founded by two former Goldman Sachs executives, and working in collaboration with some of the best teaching hospitals and medical centers in the country, Columbia Care is a patient-centered health care company aiming to set the standard of professionalism, quality, and caring in a new industry. For more information please visit www.col-care.com.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Adding a Lookup Step Makes AI Better at Assigning Medical Diagnosis Codes
Sep 25, 2025 View All Press Releases
New AI Tool Addresses Accuracy and Fairness in Data to Improve Health Algorithm
Sep 04, 2025 View All Press Releases
Study Identifies Strategy for AI Cost-Efficiency in Health Care Settings
Nov 18, 2024 View All Press Releases
AI Can Help Doctors Make Better Decisions and Save Lives
Jun 13, 2024 View All Press Releases